What Dopamine Marketing Gets Wrong
The complaint about dopamine marketing is that it stretches a real finding, and the indexed literature suggests something stranger. The vocabulary has nothing behind it in either direction, and the corrections that do exist were published to other researchers.
Answer to the question
Is dopamine really the pleasure chemical?
Not in the way the phrase suggests. Dopamine is necessary for wanting something and not for enjoying it, a dissociation established in rats depleted of almost all of theirs, which still showed normal pleasure reactions and normal learning of new likes and dislikes. The research correction was published in 1998 and again in 2007, and the commercial vocabulary has not caught up with it.
Key takeaways
- A search of the indexed biomedical literature for a dopamine detox or fast returns one item, a narrative review in a rapid-publication journal that cannot name the studies it alludes to.
- John Salamone and Mercè Correa published the correction in Neuron in 2012, calling the label of reward neurons an overgeneralisation, while the seed book credits his rat work only to the University of Connecticut.
- Schlemmer and Davis reported in 1981 that a dopamine receptor agonist produced a large dose-dependent rise in submissive macaque gestures, abolished by two receptor blockers, and the paper sits on the book's own reading list.
- David Nutt and colleagues reported in 2015 strong evidence that stimulants raise striatal dopamine levels, some evidence for alcohol, and little if any for cannabis and opiates.
The usual complaint about dopamine marketing is that it borrows a real finding and stretches it. Our search of the indexed literature suggests something stranger than a stretch. The commercial vocabulary returned almost nothing in the index we searched, one narrative review and no trial, and no published rebuttal of the kind the complaint quietly assumes is already out there.
The searches that came back empty
Start with what we looked for, because the result is a negative one and a negative result is worth nothing unless the search is named. We ran the commercial vocabulary through Europe PMC, the indexed biomedical literature, phrase by phrase. The table below is the whole return.
| Phrase paired with dopamine | What the index gives back |
|---|---|
| detox | One item, a narrative review in Cureus |
| fasting | The same single paper, nothing else |
| design | Nothing relevant: an enzyme-based biosensor and a 1997 paper on chemical sensitisation |
| hit | No study of the construct, only casual usage inside unrelated clinical papers |
| marketing, neuromarketing or social media | Nothing in any title |
One narrative review, meaning a summary of a field written without a systematic search, in a journal that publishes quickly and selects lightly. It cannot name the studies it alludes to, and its own text records the criticism that the notion has no scientific proof behind it. That is the entire indexed basis for a term now attached to detoxes, interface design, screen-time limits and a shelf of consumer books.
There is a second absence and it is the more interesting one. We could find no published rebuttal addressed to the people actually using the vocabulary. Searching for the obvious shapes, the myth paper, the misconception paper, the paper on public understanding, returns nothing on this subject. The only items in the index pairing the molecule with the word myth concern renal-dose infusions in intensive care, which is a different argument in a different room.
What the corrections say, and who they are for
The corrections do exist, which is what makes the silence odd. In 2012 John Salamone and Mercè Correa wrote in Neuron that it had become traditional to label dopamine neurons reward neurons, that this is an overgeneralisation, and that aspects of motivation are differently affected when the system is manipulated. Their positive account is about behavioural activation, the exertion of effort, approach, sustained task engagement and instrumental learning, and explicitly not about appetite or primary food motivation.
That sentence is addressed to a research readership, in a journal no marketer will ever open. There is a sharper version of the irony in our seed book. The Molecule of More, by Daniel Lieberman and Michael Long, describes the effort-based rat work at its pages 66 to 68 and credits only the University of Connecticut.
Salamone is the first author of that work. The researcher whose study the book uses without naming him is the same researcher who published the warning against exactly the shorthand the book's own prose keeps falling into.
A second correction narrows the story in a different direction. In an Opinion article in 2015, David Nutt and colleagues reported strong evidence that stimulants raise striatal dopamine levels, some evidence that alcohol may, and little evidence if any that cannabis and opiates do. Receptor availability and release are reduced in stimulant and alcohol dependence, and not in opiate, nicotine or cannabis dependence. The single-chemical account of addiction does not survive its own drug classes.
The mechanism itself we have already handled and this piece will not rebuild it. Our article wanting is not liking carries the distinction between the system that makes you pursue something and the much smaller circuitry that makes you enjoy it, along with the evidence that the two come apart. What matters here is only that the standard exists, has been in print since the 1990s, and is not what the commercial vocabulary tracks.
The macaque result and the widened thesis
The most telling page in the seed book is not an error of fact. At page 77 the authors report an experiment in which a drug raising dopamine activity produced submissive behaviour in macaques, which cuts against a thesis built on pursuit and domination. They respond by widening the thesis. Domination is redefined as domination of the environment rather than of other animals, so submission now confirms the model as well.
The paper behind that page is Schlemmer and Davis 1981, and it sits on the book's own further-reading list for that chapter. A dopamine receptor agonist, a drug that mimics the molecule at its receptor, produced a dose-dependent rise in submissive gestures. Chronic amphetamine produced the same rise with no concurrent rise in aggression directed at the treated animals. Two receptor blockers, haloperidol and pimozide, abolished the effect.
What that pharmacology will carry is narrower than it looks, and the limits belong here rather than in a footnote. It is a 1981 paper in a supplement issue, run in a social colony of a handful of adult animals, and the abstract does not give the number of monkeys. A companion paper by the same group describes a colony of four.
It was on the reading list the whole time.
So the charge is not that monkeys refute the book. It is that a result from the book's own reading list points the other way, the book reports it, and the frame then widens until the result fits inside. Credit where it is owed: the frame being widened is not the authors' invention. The acknowledgments at page xi name Fred Previc's 2009 monograph as the source of the distinction between a future-focused molecule and a group of present-focused ones, and that credit appears nowhere else in the volume.
The ledger, and what it will not settle
Set the accounts side by side, because both columns are real. The book states the anticipation account correctly, says at page 5 that dopamine activity is a reaction to the unexpected rather than a marker of pleasure, names Kent Berridge in full with his institution at page 45, and describes the central dissociation accurately. It also declares its own selection and its speculation in a boxed note before chapter one, which is more than most of this shelf manages.
Against that, the apparatus cannot support a single mechanistic claim the book makes. Each chapter closes in an unnumbered further-reading list, and there are no endnotes, no superscripts and no in-text citations anywhere in the volume. Not one of the journal articles we sampled across those lists is primary neuroscience. Chapter six explains the transporter, reuptake and cocaine and prints a labelled neuron diagram, and its twenty-three-entry list holds nothing on any of the three. Chapter seven rests its closing argument on reward prediction error, the signal that fires when an outcome turns out better or worse than expected, and its seven-entry list holds no Wolfram Schultz and no prediction-error paper of any kind.
What we cannot settle belongs in the same ledger. We reached no paywalled full text in this pass, so every finding above rests on an abstract read in full or on the book itself. The book's index was never photographed, so page 45 is the only credit to Berridge we found rather than the only one that exists. An empty search is evidence about an index, and not proof that nothing exists outside it.
We are not going to adjudicate the book. On the narrow question we do have a view, and it is that the anticipation account is right while a reading list is not a citation apparatus, which is a claim about structure rather than about anyone's intent. On the larger question, whether a popularisation that states the science correctly and cannot show its working is better or worse for a reader than silence, what we have does not decide it, and we are not going to pretend that it does.
That leaves you holding both horns. The word is now the only vocabulary most people have for wanting something before they have it, which is what makes it useful. It is also what sells the detox, the interface and the paperback, on the authority of a literature that was never addressed to any of them. Nobody has written that correction for the people using the word.
Nobody has written that correction for the people using the word.
Common questions
Is dopamine really the pleasure chemical?
Not in the way the phrase suggests, and the one-molecule-one-function version of the correction is no better. John Salamone and Mercè Correa wrote in 2012 that labelling these cells reward neurons is an overgeneralisation, and that their own positive account is about behavioural activation, the exertion of effort and approach, and explicitly not about appetite or primary food motivation. The commercial vocabulary tracks none of it.
Does a dopamine detox work?
There is no published test either way. A search of the indexed biomedical literature for a dopamine detox or fast returns one item, a narrative review in a rapid-publication journal, which cannot name the studies it alludes to and records the criticism that the idea has no scientific proof behind it. Nothing we found tests whether the practice does what it claims.
What is incentive salience?
It is the motivational tag that a cue acquires, the property that makes a sight or a smell pull you towards it rather than merely feel nice. Terry Robinson and Kent Berridge proposed it in 1993 as an account of drug craving. It is a narrow claim about cue-triggered wanting, and not a theory of how people orient to the future.
Sources
Robinson, T. E., & Berridge, K. C. (1993). 'The neural basis of drug craving: an incentive-sensitization theory of addiction.' Brain Research Reviews, 18(3), 247-291. doi:10.1016/0165-0173(93)90013-P [Abstract read in full at Europe PMC, PubMed 8401595. Author order confirmed at PubMed. METADATA TRAP: both the Crossref and the OpenAlex records for this item list only 'T Robinson' and drop Berridge entirely; do not take author lists for legacy Elsevier records from Crossref alone]
Berridge, K. C., & Robinson, T. E. (1998). 'What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?' Brain Research Reviews, 28(3), 309-369. doi:10.1016/S0165-0173(98)00019-8 [Abstract read in full at Europe PMC, PubMed 9858756. Author order confirmed at PubMed, Crossref and OpenAlex]
Berridge, K. C. (2007). 'The debate over dopamine's role in reward: the case for incentive salience.' Psychopharmacology, 191(3), 391-431. doi:10.1007/s00213-006-0578-x [Abstract read in full at Europe PMC, PubMed 17072591. DATE TRAP: Crossref and OpenAlex both give 2006, the online-first year; the issue is 2007. Cite 2007]
Salamone, J. D., & Correa, M. (2012). 'The mysterious motivational functions of mesolimbic dopamine.' Neuron, 76(3), 470-485. doi:10.1016/j.neuron.2012.10.021 [Abstract read in full at Europe PMC, PubMed 23141060; author order confirmed]
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015). 'The dopamine theory of addiction: 40 years of highs and lows.' Nature Reviews Neuroscience, 16(5), 305-312. doi:10.1038/nrn3939 [Abstract read in full at Europe PMC, PubMed 25873042; author order confirmed at Crossref and OpenAlex; open copy at kclpure.kcl.ac.uk]
Schlemmer, R. F., & Davis, J. M. (1981). 'Evidence for dopamine mediation of submissive gestures in the stumptail macaque monkey.' Pharmacology, Biochemistry, and Behavior, 14 Suppl 1, 95-102. doi:10.1016/S0091-3057(81)80016-0 [Abstract read in full at Europe PMC; author order confirmed. Full text not read]
Desai, D., Patel, J., Saiyed, F., Upadhyay, H., Kariya, P., & Patel, J. (2024). 'A Literature Review on Holistic Well-Being and Dopamine Fasting: An Integrated Approach.' Cureus, 16(6), e61643. doi:10.7759/cureus.61643 [Abstract read in full at Europe PMC, PubMed 38966464; author order confirmed]